Parallax Volatility Advisers
CVAC

Parallax Volatility Advisers’s CureVac CVAC Stock Holding History

Parallax Volatility Advisers’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-30,961
Closed -$244K – 2946
2022
Q3 		$244K Buy
30,961
+2,970
+11% +$34.6K ﹤0.01% 2251
2022
Q2 		$381K Sell
27,991
-11,961
-30% -$198K ﹤0.01% 2015
2022
Q1 		$783K Sell
39,952
-94,893
-70% -$1.89M ﹤0.01% 1754
2021
Q4 		$4.63M Buy
134,845
+53,655
+66% +$2.16M ﹤0.01% 1240
2021
Q3 		$4.43M Buy
+81,190
New +$4.89M ﹤0.01% 1290

Other funds holding CVAC

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Parallax Volatility Advisers's CVAC Position: Q4 2022 in Review

Parallax Volatility Advisers sold out of CureVac (CVAC) in Q4 2022, closing a stake of 30,961 shares — an estimated $244K sold.

Parallax Volatility Advisers first reported a position in CVAC in Q3 2021 and held it in 5 quarters. The position peaked at $4.63M in Q4 2021. 82 funds tracked by Wall St. Rank hold CVAC as of Q4 2022.

  • Parallax Volatility Advisers reported no remaining CureVac position as of Q4 2022 after selling out during the quarter.
  • Parallax Volatility Advisers sold 30,961 CureVac shares in Q4 2022, an estimated $244K.
  • Parallax Volatility Advisers first reported a position in CureVac in Q3 2021 and held it in 5 quarters.
  • Parallax Volatility Advisers's CureVac position peaked at $4.63M in Q4 2021.
  • 82 funds tracked by Wall St. Rank held CureVac as of Q4 2022.

Based on Parallax Volatility Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.